Hansoh Pharmaceutical Group CoHNSPF 90 Dividend Payout Ratio is 0.54 as of Dec. 2025, which is 86% above its 10-year median of 0.29. GuruFocus rates HNSPF with a GF Scoreâ„¢ of 90/100 and a GF Valueâ„¢ of $3.00 (Modestly Overvalued). Among 444 Drug Manufacturers companies, Hansoh Pharmaceutical Group Co ranks better than 53.6% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Hansoh Pharmaceutical Group Co's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.54.
The historical rank and industry rank for Hansoh Pharmaceutical Group Co's Dividend Payout Ratio or its related term are showing as below:
HNSPF'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.29 Max: 0.43
Current: 0.36
During the past 10 years, the highest Dividend Payout Ratio of Hansoh Pharmaceutical Group Co was 0.43. The lowest was 0.15. And the median was 0.29.
HNSPF's Dividend Payout Ratio is ranked better than 53.6% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs HNSPF: 0.36
During the past 10 years, the highest Trailing Annual Dividend Yield of Hansoh Pharmaceutical Group Co was 2.06%. The lowest was 0.41%. And the median was 0.90%.
During the past 12 months, Hansoh Pharmaceutical Group Co's average Dividends Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 39.40% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Hansoh Pharmaceutical Group Co was 63.20% per year. The lowest was 39.40% per year. And the median was 51.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Hansoh Pharmaceutical Group Co (OTCPK:HNSPF) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Hansoh Pharmaceutical Group Co Dividend Payout Ratio Related Terms
Hansoh Pharmaceutical Group Co Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co Dividend Payout Ratio Chart
HNSPF vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hansoh Pharmaceutical Group Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's Dividend Payout Ratio falls into.
Hansoh Pharmaceutical Group Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HNSPF) has a Dividend Payout Ratio of 0.54 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hansoh Pharmaceutical Group Co and its competitors. This is 86% above median its historical median of 0.29. Over the past decade, Hansoh Pharmaceutical Group Co's Dividend Payout Ratio has ranged from 0.15 to 0.43. According to the industry distribution chart, Hansoh Pharmaceutical Group Co ranks #206 out of 444 companies in the Drug Manufacturers industry, placing it in the top 46.4%.
Is Hansoh Pharmaceutical Group Co's Dividend Payout Ratio too high?
Hansoh Pharmaceutical Group Co's current Dividend Payout Ratio of 0.54 is 86% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 0.43. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Hansoh Pharmaceutical Group Co's value of 0.54 is 44% above this industry median. Based on the distribution chart, Hansoh Pharmaceutical Group Co ranks #206 out of 444 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hansoh Pharmaceutical Group Co has a GF Scoreâ„¢ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hansoh Pharmaceutical Group Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hansoh Pharmaceutical Group Co ranks #206 out of 444 companies for Dividend Payout Ratio. This puts Hansoh Pharmaceutical Group Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.38. Hansoh Pharmaceutical Group Co's value of 0.54 is 44% above this benchmark. Historically, Hansoh Pharmaceutical Group Co's own Dividend Payout Ratio has ranged from 0.15 to 0.43 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.38, Hansoh Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hansoh Pharmaceutical Group Co's current Dividend Payout Ratio of 0.54 is 44% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hansoh Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hansoh Pharmaceutical Group Co's current Dividend Payout Ratio is 0.54, which is 86% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hansoh Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co (HNSPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.00, compared to a current price of $3.83 — trading 27.5% above its estimated fair value. The current Dividend Payout Ratio is 0.54, which is 86% above median its 10-year median of 0.29 and 44% above the Drug Manufacturers industry median of 0.38. Hansoh Pharmaceutical Group Co's overall GF Score™ is 90/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Hansoh Pharmaceutical Group Co (HNSPF), the current Dividend Payout Ratio is 0.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hansoh Pharmaceutical Group Co (HNSPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hansoh Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of $3.83 is trading 27.5% above its estimated GF Value™ of $3.00.
GuruFocus considers Hansoh Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for HNSPF:
Dividend Payout Ratio: 0.54 (86% above median its 10-year median of 0.29)
GF Value™: $3.00 vs. price of $3.83 (27.5% above fair value)
Industry Position: 44% above the Drug Manufacturers median (#206 of 444)
No single metric tells the full story. See the HNSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hansoh Pharmaceutical Group Co Business Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
90GF Score
Get the complete analysis for HNSPF
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HNSPF has been successfully added to your 
